Biblio
Orai1 promotes tumor progression by enhancing cancer stemness via NFAT signaling in oral/oropharyngeal squamous cell carcinoma. Oncotarget. 2016.
. Orai1α and Orai1β support calcium entry and mammosphere formation in breast cancer stem cells. Sci Rep. 2023;13(1):19471.
. Oral administration of Bifidobacterium breve improves anti-angiogenic drugs-derived oral mucosal wound healing impairment via upregulation of interleukin-10. Int J Oral Sci. 2023;15(1):56.
. Oral administration of green tea Epigallocatechin-3-gallate reduces oxidative stress and enhances restoration of cardiac function in diabetic rats receiving autologous transplantation of adipose-derived stem cells. Arch Physiol Biochem. 2019:1-8.
Oral administration of hydroxylated-graphene quantum dots induces intestinal injury accompanying the loss of intestinal stem cells and proliferative progenitor cells. Nanotoxicology. 2019:1-13.
. Oral Administration of LB-P9 Promotes Hair Regeneration in Mice. Food Sci Anim Resour. 2024;44(1):204-215.
. Oral and Gut Microbiota Dysbiosis is Associated with Mucositis Severity in Autologous Hematopoietic Stem Cell Transplant: Evidence from an Asian Population. Transplant Cell Ther. 2023.
. Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients. Clin Microbiol Infect. 2023.
. Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort. Br J Haematol. 2023.
Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study). Leuk Lymphoma. 2019:1-9.
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2023.
. Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission. N Engl J Med. 2020;383(26):2526-2537.
Oral Biosciences: The annual review 2021. J Oral Biosci. 2022.
. Oral Biosciences: The annual review 2022. J Oral Biosci. 2023.
. Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease. Rev Bras Hematol Hemoter. 2014;36(1):65-8.
. Oral cancer stem cells drive tumourigenesis through activation of stromal fibroblasts. Oral Dis. 2020.
. Oral Candida carriage and resistance against common antifungal agents in hematopoietic stem cell transplantation recipients. Support Care Cancer. 2024;32(3):185.
. Oral chronic graft-versus-host disease: analysis of dendritic cells subpopulations. An Bras Dermatol. 2014;89(4):632-637.
. Oral Chronic Graft-versus-Host Disease in Post-Hematopoietic Stem Cell Transplant Patients Following SARS-CoV-2 Vaccination: Case Reports. Case Rep Oncol. 2023;16(1):1287-1292.
. Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists. Support Care Cancer. 2014.
. Oral complications and dental care in children with acute lymphoblastic leukaemia. J Oral Pathol Med. 2014.
. Oral Complications and Management Strategies for Patients Undergoing Cancer Therapy. ScientificWorldJournal. 2014;2014:581795.
. Oral Complications in Hematopoietic Stem Cell Recipients: The Role of Inflammation. Mediators Inflamm. 2014;2014:378281.
. Oral Complications of Chronic Graft-Versus-Host Disease. J Natl Cancer Inst Monogr. 2019;2019(53).
. .